Catalyst Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US14888U1016
USD
23.08
0.46 (2.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
491.73
398.20
214.20
140.83
119.07
102.31
0.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
491.73
398.20
214.20
140.83
119.07
102.31
0.50
Raw Material Cost
106.22
84.53
34.39
21.88
17.04
14.76
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
177.74
133.71
58.18
49.63
44.23
36.88
15.84
Other Expenses
1.26
9.31
1.98
1.69
1.65
1.88
1.99
Total Expenditure (Excl Depreciation)
296.61
311.39
112.36
88.45
77.77
70.48
35.76
Operating Profit (PBDIT) excl Other Income
195.10000000000002
86.8
101.8
52.400000000000006
41.3
31.8
-35.3
Other Income
16.06
7.70
2.88
0.28
0.59
1.49
1.32
Operating Profit (PBDIT)
249.24
127.65
106.20
53.15
42.78
33.61
-33.94
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
5.08
0.00
0.00
0.00
0.00
0.10
-0.03
Gross Profit (PBDT)
385.51
313.67
179.81
118.95
102.03
87.55
0.00
Depreciation
38.05
33.14
1.49
0.48
0.89
0.30
0.04
Profit Before Tax
216.26
94.51
104.72
52.67
41.89
33.41
-34.00
Tax
52.37
23.10
21.64
13.19
-33.09
1.53
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
163.89
71.41
83.08
39.48
74.98
31.88
-34.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
163.89
71.41
83.08
39.48
74.98
31.88
-34.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
163.89
71.41
83.08
39.48
74.98
31.88
-34.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
727.63
387.88
300.42
206.83
169.60
87.63
50.78
Earnings per share (EPS)
1.31
0.63
0.75
0.37
0.71
0.3
-0.33
Diluted Earnings per share
1.31
0.63
0.75
0.37
0.71
0.3
-0.33
Operating Profit Margin (Excl OI)
39.68%
21.8%
47.54%
37.2%
34.69%
31.11%
-7059.03%
Gross Profit Margin
51.72%
32.06%
49.58%
37.74%
35.92%
32.95%
-6793.11%
PAT Margin
33.33%
17.93%
38.79%
28.03%
62.97%
31.16%
-6800.7%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 23.48% vs 85.90% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 129.55% vs -14.08% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 94.33% vs 16.17% in Dec 2023

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Catalyst Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
491.73
36.50
455.23
1,247.21%
Other Operating Income
0.00
0.00
0.00
Total Operating income
491.73
36.50
455.23
1,247.21%
Raw Material Cost
106.22
9.82
96.40
981.67%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
177.74
156.78
20.96
13.37%
Other Expenses
1.26
29.56
-28.30
-95.74%
Total Expenditure (Excl Depreciation)
296.61
462.23
-165.62
-35.83%
Operating Profit (PBDIT) excl Other Income
195.12
-425.74
620.86
145.83%
Other Income
16.06
1,143.71
-1,127.65
-98.60%
Operating Profit (PBDIT)
249.24
723.62
-474.38
-65.56%
Interest
0.00
0.00
0.00
Exceptional Items
5.08
0.00
5.08
Gross Profit (PBDT)
385.51
26.68
358.83
1,344.94%
Depreciation
38.05
5.65
32.40
573.45%
Profit Before Tax
216.26
717.97
-501.71
-69.88%
Tax
52.37
44.24
8.13
18.38%
Provisions and contingencies
0
0
0.00
Profit After Tax
163.89
673.73
-509.84
-75.67%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
163.89
673.73
-509.84
-75.67%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
163.89
673.73
-509.84
-75.67%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
727.63
1,540.96
-813.33
-52.78%
Earnings per share (EPS)
1.31
11.64
-10.33
-88.75%
Diluted Earnings per share
1.31
11.64
-10.33
-88.75%
Operating Profit Margin (Excl OI)
39.68%
-1,166.47%
0.00
1,206.15%
Gross Profit Margin
51.72%
1,982.63%
0.00
-1,930.91%
PAT Margin
33.33%
1,845.92%
0.00
-1,812.59%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 49.17 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 23.48% vs 85.90% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 16.39 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 129.55% vs -14.08% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.32 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 94.33% vs 16.17% in Dec 2023

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 39.68%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023